|
4
|
29
|
2c90A |
Thrombin inhibitors |
|
1
|
27
|
2bvsL |
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket |
|
58
|
257
|
2bxuH |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
59
|
250
|
2bvrH |
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket |
|
1
|
27
|
2bxuL |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
58
|
257
|
2bvsH |
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket |
|
46
|
257
|
2bvxH |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
1
|
27
|
2bvxL |
Design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker |
|
1
|
27
|
2bvrL |
Human thrombin complexed with fragment-based small molecules occupying the s1 pocket |
|
3
|
47
|
2b5tA |
2.1 angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic sr123781 and two s195a thrombin molecules |
|
78
|
286
|
2bdyA |
Thrombin in complex with inhibitor |
|
50
|
259
|
2afqB |
1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state |
|
56
|
257
|
2anmH |
Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor |
|
2
|
34
|
2ankL |
Orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide |
|
57
|
259
|
2b5tB |
2.1 angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic sr123781 and two s195a thrombin molecules |
|
54
|
257
|
2ankH |
Orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide |
|
2
|
34
|
2anmL |
Ternary complex of an orally active thrombin inhibitor with human thrombin and a c-terminal hirudin derived exo-sit inhibitor |
|
2
|
29
|
2afqA |
1.9 angstrom crystal structure of wild-type human thrombin in the sodium free state |
|
1
|
32
|
2a45A |
Crystal structure of the complex between thrombin and the central "e" region of fibrin |
|
0
|
41
|
2a1dA |
Staphylocoagulase bound to bovine thrombin |
|
62
|
287
|
1zrbA |
Thrombin in complex with an azafluorenyl inhibitor 23b |
|
64
|
287
|
1zgvA |
Thrombin in complex with an oxazolopyridine inhibitor 2 |
|
2
|
34
|
2a2xL |
Orally active thrombin inhibitors in complex with thrombin inh12 |
|
64
|
287
|
1zgiA |
Thrombin in complex with an oxazolopyridine inhibitor 21 |
|
55
|
257
|
2a2xH |
Orally active thrombin inhibitors in complex with thrombin inh12 |
|
39
|
258
|
2a45B |
Crystal structure of the complex between thrombin and the central "e" region of fibrin |
|
3
|
30
|
2a0qA |
Structure of thrombin in 400 mm potassium chloride |
|
48
|
259
|
2a1dB |
Staphylocoagulase bound to bovine thrombin |
|
53
|
257
|
2a0qB |
Structure of thrombin in 400 mm potassium chloride |
|
66
|
287
|
1z71A |
Thrombin and p2 pyridine n-oxide inhibitor complex structure |
|
1
|
40
|
1z8jA |
Crystal structure of the thrombin mutant g193p bound to ppack |
|
1
|
39
|
1z8iA |
Crystal structure of the thrombin mutant g193a bound to ppack |
|
46
|
257
|
1z8jB |
Crystal structure of the thrombin mutant g193p bound to ppack |
|
52
|
257
|
1z8iB |
Crystal structure of the thrombin mutant g193a bound to ppack |
|
1
|
27
|
1ypjL |
Thrombin inhibitor complex |
|
2
|
27
|
1ypmL |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1014 |
|
18
|
101
|
1ycpM |
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe-8 to tyrosine strongly inhibits normal cleavage at arginine-16 |
|
58
|
257
|
1ypeH |
Thrombin inhibitor complex |
|
59
|
257
|
1ypkH |
Thrombin inhibitor complex |
|
3
|
29
|
1ycpJ |
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe-8 to tyrosine strongly inhibits normal cleavage at arginine-16 |
|
2
|
27
|
1yplL |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1008 |
|
2
|
27
|
1ypkL |
Thrombin inhibitor complex |
|
54
|
255
|
1ycpH |
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe-8 to tyrosine strongly inhibits normal cleavage at arginine-16 |
|
57
|
257
|
1yplH |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1008 |
|
2
|
27
|
1ypgL |
Thrombin inhibitor complex |
|
59
|
257
|
1ypmH |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1014 |
|
58
|
257
|
1ypjH |
Thrombin inhibitor complex |
|
12
|
146
|
1ycpK |
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe-8 to tyrosine strongly inhibits normal cleavage at arginine-16 |
|
58
|
257
|
1ypgH |
Thrombin inhibitor complex |
|
3
|
27
|
1ypeL |
Thrombin inhibitor complex |
